Authors
Latest:
Any Willing Provider Legislation May Squeeze Independent Practice PharmaciesIndependents grapple with increasingly aggressive policies among payers, pharmacy benefit managers, and pharma companies.
Latest:
Predictive Analytics: A Case Study in Machine-Learning and Claims DatabasesA state-of-the-art predictive analysis tool that finds patients with rare diseases in a complex database could be valuable to stakeholders, who would achieve savings by helping physicians prescribe the appropriate treatment sooner.
Latest:
Gaps in Immunization MeasurementIn the United States, vaccine-preventable diseases cause tens of thousands of deaths each year.
Latest:
Taking Medication in Diabetes Self-Management: Issues and Recommendations for Reducing BarriersThis paper considers opportunities and barriers relating to medication taking and self-management by people with diabetes and related conditions as discussed during an invitational symposium.
Latest:
Enterovirus May Have PeakedEnterovirus-D68 could soon be in the rearview mirror, according to a Hartford, CT, pediatric intensivist who has treated more than 20 children hospitalized with the infection.
Latest:
Impact of Risk Evaluation and Mitigation Strategies in OncologyWhen used fittingly, REMS can ensure safe use of prescribed drugs. However, applying REMS to oncology and supportive-care drugs must be done carefully.
Latest:
SBRT Improves Options for Prostate CancerFor some patients, stereotactic body radiation therapy may provide an enhanced quality of life, better efficacy, and reduced adverse effects.
Latest:
What Are Treatment Approaches to Liver Cancer?How to treat hepatocellular carcinoma is heavily influenced by the burden of disease at diagnosis.
Latest:
Avoidable ReadmissionsIn the past year, more than 2200 hospitals have been penalized $280 million for "excessive" readmission rates under the Centers for Medicare & Medicaid Services' Readmissions Reduction Program, and the penalties will become more severe as the maximum penalty rises to 3% by 2014.
Latest:
340B Program Compliance Tools Vary in Ability, AccuracyTechnology is essential, but not all solutions meet every goal or offer the same capabilities.
Latest:
Work Productivity Associated With Treated Versus Never-Treated Overactive Bladder SymptomsOveractive bladder symptoms can impair work productivity, especially among untreated adults, with work productivity impairment costs nearly twice as high for never-treated versus treated subjects.
Latest:
What Roles Do Patient Characteristics Play in Value-Based Performance?Incorporating patient-related sociodemographic factors into performance measurement systems is essential for providing an accurate assessment of the quality of care delivered.
Latest:
Hemophilia and Managed Care: Partnering to Achieve Cost-Effective CareExploring how health plans and hemophilia treatment centers can better work together to deliver high-quality care and manage costs associated with hemophilia.
Latest:
Dapagliflozin/Saxagliptin to Treat Inadequately Controlled Type 2 DiabetesDoes this antihyperglycemic combination medication need to be added to a formulary?
Latest:
Zooming Through the Pandemic: NSU Virtual AMCP Student ChapterThere are many benefits to adopting and integrating new technological methods for hosting pharmacy organization events.
Latest:
Potentially Inappropriate Prescribing of Direct-acting Oral Anticoagulants in the Veterans Health AdministrationThis study examines variations in overall use, and potentially inappropriate use, of non-warfarin direct-acting oral anticoagulants across sites within the Veterans Health Administration.
Latest:
Setting Prices for Generic Medications: A Survey of Patient's PerceptionsThe greater use of generic prescription medications has been widely advocated as a policy solution to rising healthcare costs.
Latest:
RFID Technology and the DSCSA: Paving the Way for a New Standard in Patient CareThe Drug Supply Chain Security Act (DSCSA) will soon mandate end-to-end tracking of pharmaceuticals throughout the supply chain, with numerous benefits for health systems.
Latest:
A System Approach to Pharmacy LeadershipHospital acquisitions and mergers have become common in today's health care environment.
Latest:
Defining the Teriparatide Patient: Osteoporosis Sequence of Care and Healthcare ResourcesThis study provides real-world evidence of a teriparatide (TPTD) patient’s characteristics, sequence of care, and healthcare resource utilization, and compares TPTD patients with non-TPTD patients.
Latest:
Amino Acid L-Serine in Preventing Neurodegenerative Diseases Associated with BMAAInsights into possible treatments for disorders that range from demyelination to plaque formation and misfolded proteins.
Latest:
NCCN Guidelines: Rapid Change in CLL Treatment ConceptsTaylor M. Weis, PharmD, BCOP, discusses NCCN guidelines for first-line therapy as well as the rationale behind the rapid change in treatment concepts for CLL.
Latest:
Hospital Formulary ManagementThe creation and continuous evaluation of a hospital’s formulary facilitates superior patient care, achieves therapeutic goals, and improves patient safety while curtailing expenses.
Latest:
Growth Hormone Therapy Guidelines: Clinical and Managed Care PerspectivesCurrent treatment guidelines utilized by healthcare provider organizations and managed care organization insurance coverage policies for growth hormone therapy are reviewed.
Latest:
Is CREATES a Solution to Rising Drug Costs?The Creating and Restoring Equal Access to Equivalent Samples Act of 2017 aims to expedite the entry of lower-cost biosimilars and generics into the market.
Latest:
Ready for New Rules on Hazardous Drug Management?The US Pharmacopeia (USP) Convention’s General Chapter draft guidelines have already raised the bar for hazardous drug management and imposed costs for compliance.
